News & Insights
Comparing & Contrasting the Divergent Litigation Pathways of Small vs. Large Molecule Products: Examining the Impact of Differing Regulatory Schemes, Challenges Created Under the AIA & Lessons Learned from Recent Biosimilars Litigation in the US & Abroad
New York, NY
September 23, 2013
Event Sponsor: The International Congress on Paragraph IV Litigation